Chronic News and Research

RSS

Study shows genetic link between endometriosis and ovarian cancer subtypes

University of Queensland researchers have demonstrated a genetic link between endometriosis and ovarian cancer subtypes enabling them to identify potential drug targets for therapy and increasing the understanding of both diseases.

15 Mar 2022

Small airways disease is a potential long-lasting effect of COVID-19, study says

Disease of the small airways in the lungs is a potential long-lasting effect of COVID-19, according to a new study published in the journal Radiology.

15 Mar 2022

‘An Arm and a Leg’: Need an expensive drug? Here’s what you need to know

Lillian Karabaic teaches personal finance to millennials through a podcast and community called Oh My Dollar! — and she needs an expensive drug to treat a chronic condition.

15 Mar 2022

Study results in three new co-amorphous drug systems with great anti-COVID-19 potential

Researchers demonstrated that the bioavailability of matrine-type alkaloids could be prolonged by employing a co-former, resveratrol.

15 Mar 2022

Patients taking prescription opioids are at higher risk of developing mood disorders

People who are prescribed opioids for pain relief have a higher risk of developing mood disorders such as anxiety, University of Queensland researchers have found.

14 Mar 2022

New computational biology method deciphers gut microbiome ‘chatter’ to fight IBD

Around 500,000 people in the UK live with Inflammatory Bowel Disease (IBD), a life-long, chronic condition characterized by sporadic bouts of gut inflammation causing debilitating symptoms.

14 Mar 2022

Current evidence that vitamin D is effective against COVID-19 neurological sequelae

Researchers analyze the available scientific evidence supporting vitamin D as a neuroprotective agent against the neurological sequelae of COVID-19.

14 Mar 2022

New update on using masks in the public transportation corridor

At CDC's recommendation, TSA will extend the security directive for mask use on public transportation and transportation hubs for one month, through April 18th.

11 Mar 2022

Antibody treatment improves symptoms of neuromyelitis optica in a rat model

Autoimmune diseases are the molecular equivalent of "friendly fire": the body attacks itself instead of harmful invaders.

11 Mar 2022

Meta-analysis finds intensified anticoagulation had no effect on short term mortality among hospitalized COVID-19 patients

A recent systematic review and meta-analysis evaluated the safety and efficacy of intensified anticoagulation therapy in COVID-19 patients.

11 Mar 2022

Genomic surveillance of bacterial colonies could help physicians keep closer tabs on drug resistance

Antibiotic-resistant bacterial infections are difficult to treat and cause more than a million annual deaths worldwide, especially in hospitalized patients with pneumonia, bloodstream infections, urinary tract infections, or abdominal infections.

11 Mar 2022

Most cancer patients develop antibodies after receiving COVID-19 vaccine, study shows

Cancer patients who have compromised immune systems due to their disease or therapy remain at high risk for COVID-19 infection.

10 Mar 2022

Cellular therapy offers promise for patients with Duchenne muscular dystrophy, trial shows

A clinical trial at UC Davis Health and six other sites showed that a cellular therapy offers promise for patients with late-stage Duchenne muscular dystrophy (DMD), a rare genetic disorder causing muscle loss and physical impairments in young people.

10 Mar 2022

New study analyzes COVID-19 outcomes in patients with cancer

If a cancer patient tests positive for COVID-19, are they more likely to become hospitalized from the disease?

10 Mar 2022

Pioneering kidney disease research at Leicester receives a major boost on World Kidney Day

Pioneering research by the University of Leicester into chronic kidney disease has received a major boost on World Kidney Day (10th March 2022) following a generous £1million donation from long-term supporter and kidney health advocate Jimmy Mayer.

10 Mar 2022

Targeting regulation of subcellular architecture may hold opportunities to treat metabolic diseases

Cells use their molecular architecture to regulate their metabolic functions, and repairing diseased cells' architecture to a healthier state can also repair metabolism, according to a study led by Harvard T.H. Chan School of Public Health researchers.

10 Mar 2022

Chronic News and Research

Study shows genetic link between endometriosis and ovarian cancer subtypes

Small airways disease is a potential long-lasting effect of COVID-19, study says

‘An Arm and a Leg’: Need an expensive drug? Here’s what you need to know

Study results in three new co-amorphous drug systems with great anti-COVID-19 potential

Patients taking prescription opioids are at higher risk of developing mood disorders

New computational biology method deciphers gut microbiome ‘chatter’ to fight IBD

Current evidence that vitamin D is effective against COVID-19 neurological sequelae

New update on using masks in the public transportation corridor

Antibody treatment improves symptoms of neuromyelitis optica in a rat model

Meta-analysis finds intensified anticoagulation had no effect on short term mortality among hospitalized COVID-19 patients

Genomic surveillance of bacterial colonies could help physicians keep closer tabs on drug resistance

Most cancer patients develop antibodies after receiving COVID-19 vaccine, study shows

Cellular therapy offers promise for patients with Duchenne muscular dystrophy, trial shows

New study analyzes COVID-19 outcomes in patients with cancer

Pioneering kidney disease research at Leicester receives a major boost on World Kidney Day

Targeting regulation of subcellular architecture may hold opportunities to treat metabolic diseases

Older female cancer survivors face challenges with physical activity due to chronic lower extremity lymphedema

Sporadic Legionnaires’ disease in commercial truck drivers could be attributed to vehicle windshield wiper fluid

Association of benzodiazepines with SARS-CoV-2 positivity and clinical outcomes in three patient groups

Long COVID symptoms in families a year after SARS-CoV-2 infection or household exposure

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News